Nexam Chemical Holding AB (publ) (NEXAM.ST)
Lomma, SE
Nexam Chemical Holding AB (publ) specializes in creating advanced chemical solutions designed to elevate the properties and performance of various polymers. Operating globally, with a strong presence in Sweden and Europe, the company delivers products that boost the characteristics and durability of materials like polyesters, polyethylene, polyamides, polyimides, and high-temperature resins. Their offerings also encompass functional chemicals, additive and functional masterbatches, and color masterbatches and compounds, marketed under the NEXAMITE and NEXIMID brands. Furthermore, Nexam Chemical provides innovative polymer and reactive recycling solutions. The firm caters to diverse sectors including aerospace, electronics, piping, and advanced foam manufacturing. Established in 2009, its headquarters are located in Lomma, Sweden.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.77% | +7.84% | +38.66% | +38.08% | +17.86% | +37.50% | -13.39% | -8.84% | -76.17% | -72.84% | -54.79% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-3.7% Q1'26: -11.0% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-81.8% Q1'26: -41.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-0.1% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%-6.4% Q1'26: -12.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%-6.7% Q1'26: -11.4% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.0% Q1'26: +8.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×6.84× Q1'26: -3.58× (vs Q1'25)
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
7.84M
est: 14.40M (-45.5%)
|
8.27M
est: 14.40M (-42.6%)
|
18.69M
est: 57.00M (-67.2%)
|
109.84M
est: 109.70M (+0.1%)
|
130.06M
est: 132.02M (-1.5%)
|
165.83M
est: 164.39M (+0.9%)
|
219.45M
est: 225.05M (-2.5%)
|
221.76M
est: 228.40M (-2.9%)
|
190.28M
est: 203.27M (-6.4%)
|
199.58M
est: 201.00M (-0.7%)
|
192.25M
est: 229.41M (-16.2%)
|
207.44M
207.44M – 207.44M
-9.6% YoY
|
235.67M
235.67M – 235.67M
+13.6% YoY
|
265.64M
265.64M – 265.64M
+12.7% YoY
|
| EBITDA |
-18.95M
est: 256.9K (-7,476.1%)
|
-19.49M
est: 256.9K (-7,683.5%)
|
-19.82M
est: 1.02M (-2,049.1%)
|
-6.38M
est: 1.96M (-426.0%)
|
-6.04M
est: 2.36M (-356.6%)
|
5.08M
est: 2.93M (+73.1%)
|
6.30M
est: 4.02M (+56.8%)
|
780.0K
est: 4.08M (-80.9%)
|
-5.01M
est: 3.25M (-253.9%)
|
10.52M
est: 3.22M (+226.9%)
|
4.12M
est: 3.67M (+12.3%)
|
3.32M
3.32M – 3.32M
-9.6% YoY
|
3.77M
3.77M – 3.77M
+13.6% YoY
|
4.25M
4.25M – 4.25M
+12.7% YoY
|
| EBIT |
-21.75M
est: -657.8K (-3,206.2%)
|
-21.92M
est: -657.8K (-3,232.6%)
|
-22.79M
est: -2.60M (-775.2%)
|
-15.66M
est: -5.01M (-212.6%)
|
-15.39M
est: -6.03M (-155.1%)
|
-5.12M
est: -7.51M (+31.9%)
|
-4.28M
est: -10.28M (+58.4%)
|
-11.23M
est: -10.43M (-7.6%)
|
-19.61M
est: -10.64M (-84.2%)
|
-4.87M
est: -10.53M (+53.8%)
|
-12.36M
est: -12.01M (-2.9%)
|
-10.86M
-10.86M – -10.86M
+9.6% YoY
|
-12.34M
-12.34M – -12.34M
-13.6% YoY
|
-13.91M
-13.91M – -13.91M
-12.7% YoY
|
| Net Income |
-23.71M
est: -42.08M (+43.7%)
|
-22.09M
est: -42.08M (+47.5%)
|
-5.75M
est: -12.95M (+55.6%)
|
-17.18M
est: 12.95M (-232.7%)
|
-17.07M
est: -18.45M (+7.5%)
|
-8.09M
est: -5.86M (-38.0%)
|
-5.47M
est: -880.6K (-520.6%)
|
-12.71M
est: -11.47M (-10.8%)
|
-22.84M
est: -9.98M (-128.8%)
|
-9.01M
est: -6.47M (-39.2%)
|
-16.53M
est: 11.05M (-249.7%)
|
-9.33M
-9.33M – -9.33M
-184.5% YoY
|
3.50M
3.50M – 3.50M
+137.5% YoY
|
12.89M
12.89M – 12.89M
+268.8% YoY
|
| SGA |
12.30M
est: 3.61M (+240.7%)
|
9.19M
est: 3.61M (+154.7%)
|
12.13M
est: 14.28M (-15.1%)
|
24.34M
est: 27.49M (-11.5%)
|
28.75M
est: 33.09M (-13.1%)
|
34.16M
est: 41.20M (-17.1%)
|
41.62M
est: 56.40M (-26.2%)
|
87.47M
est: 57.24M (+52.8%)
|
88.10M
est: 42.57M (+107.0%)
|
—
est: 42.09M (-100.0%)
|
—
est: 48.04M (-100.0%)
|
43.44M
43.44M – 43.44M
-9.6% YoY
|
49.35M
49.35M – 49.35M
+13.6% YoY
|
55.63M
55.63M – 55.63M
+12.7% YoY
|
| EPS |
-0.46
est: -0.52 (+11.5%)
|
-0.36
est: -0.52 (+30.8%)
|
-0.09
est: -0.16 (+43.8%)
|
-0.25
est: 0.16 (-256.3%)
|
-0.25
est: -0.23 (-9.6%)
|
-0.11
est: -0.07 (-51.9%)
|
-0.07
est: -0.01 (-537.7%)
|
-0.16
est: -0.14 (-12.9%)
|
-0.28
est: -0.12 (-126.9%)
|
-0.11
est: -0.08 (-37.5%)
|
-0.20
est: 0.14 (-246.5%)
|
-0.12
-0.12 – -0.12
-184.5% YoY
|
0.04
0.04 – 0.04
+137.5% YoY
|
0.16
0.16 – 0.16
+268.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-28 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-27 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-26 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-25 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-22 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-21 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-20 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-19 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-18 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-15 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-13 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-12 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-11 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-08 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-07 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-06 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-05 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-05-04 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-30 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-24 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ronnie Tornqvist | Chief Executive Officer | 4M | male |
| Daniel Röme | Co-Founder | 83.0K | male |
| Christer Svanberg | Chief Technology Officer | — | male |
| Jorgen Heby | Chief Production Officer | — | — |
| Lazlo Megyeri | MD & Chief Executive Officer of Hungary | — | male |
| Marcus Nyberg | Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NEXAM.ST
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
